REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS. (2025). International Research Journal of Pharmacy, 16(2), 38-49. https://doi.org/10.56802/y0zhqk37